QUALTRAK Trademark

Trademark Overview

On Monday, April 25, 2022, a trademark application was filed for QUALTRAK with the United States Patent and Trademark Office. The USPTO has given the QUALTRAK trademark a serial number of 97380331. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Tuesday, September 17, 2024. This trademark is owned by Applied Biosystems LLC. The QUALTRAK trademark is filed in the Pharmaceutical Products category with the following description:

Biopharmaceutical laboratory reagents, oligonucleotides, primers and probes, enzymes and enzyme mixes, nucleotide sets and nucleotide mixes, fluorescent dye, all the foregoing for in-vitro medical, clinical or biopharmaceutical use, reaction buffers and sample detection labels in the form of strips of adhesive paper labels for laboratory use for nucleic acid genotyping tools, nucleic acid quantification and nucleic acid amplification including polymerase chain reactions, and reverse transcription polymerase chain reactions, for gene expression, genotyping, microbial testing applications all the foregoing for in-vitro medical, clinical or biopharmaceutical use; Kits comprised of laboratory reagents, oligonucleotides, primers and probes, enzymes and enzyme mixes, nucleotide sets and nucleotide mixes, fluorescent dye, all the foregoing for in-vitro medical, clinical, and biopharmaceutical use, reaction buffers and sample detection labels in the form of strips of adhesive paper labels for ...
qualtrak

General Information

Serial Number97380331
Word MarkQUALTRAK
Filing DateMonday, April 25, 2022
Status730 - FIRST EXTENSION - GRANTED
Status DateTuesday, September 17, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 13, 2024

Trademark Statements

Goods and ServicesBiopharmaceutical laboratory reagents, oligonucleotides, primers and probes, enzymes and enzyme mixes, nucleotide sets and nucleotide mixes, fluorescent dye, all the foregoing for in-vitro medical, clinical or biopharmaceutical use, reaction buffers and sample detection labels in the form of strips of adhesive paper labels for laboratory use for nucleic acid genotyping tools, nucleic acid quantification and nucleic acid amplification including polymerase chain reactions, and reverse transcription polymerase chain reactions, for gene expression, genotyping, microbial testing applications all the foregoing for in-vitro medical, clinical or biopharmaceutical use; Kits comprised of laboratory reagents, oligonucleotides, primers and probes, enzymes and enzyme mixes, nucleotide sets and nucleotide mixes, fluorescent dye, all the foregoing for in-vitro medical, clinical, and biopharmaceutical use, reaction buffers and sample detection labels in the form of strips of adhesive paper labels for laboratory use for nucleic acid genotyping, nucleic acid quantification and nucleic acid amplification including polymerase chain reaction and reverse transcription polymerase chain reactions, all the foregoing for in-vitro medical, or biopharmaceutical use.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, May 2, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameApplied Biosystems LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressSouth San Francisco, CA 94080
Party NameApplied Biosystems LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressSouth San Francisco, CA 94080

Trademark Events

Event DateEvent Description
Monday, May 2, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, April 28, 2022NEW APPLICATION ENTERED
Friday, February 10, 2023ASSIGNED TO EXAMINER
Friday, February 10, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, February 13, 2023LETTER OF PROTEST EVIDENCE FORWARDED
Monday, February 13, 2023LETTER OF PROTEST EVIDENCE REVIEWED-NO FURTHER ACTION TAKEN
Thursday, February 16, 2023ATTORNEY REVIEW COMPLETED
Tuesday, February 28, 2023WITHDRAWN FROM PUB - OG REVIEW QUERY
Tuesday, May 2, 2023PREVIOUS ALLOWANCE COUNT WITHDRAWN
Tuesday, May 9, 2023NON-FINAL ACTION WRITTEN
Tuesday, May 9, 2023NON-FINAL ACTION E-MAILED
Tuesday, May 9, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, August 1, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, August 1, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, August 2, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, September 2, 2023FINAL REFUSAL WRITTEN
Saturday, September 2, 2023FINAL REFUSAL E-MAILED
Saturday, September 2, 2023NOTIFICATION OF FINAL REFUSAL EMAILED
Friday, October 13, 2023TEAS VOLUNTARY AMENDMENT RECEIVED
Friday, October 13, 2023PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Wednesday, November 8, 2023ACTION REQ FOR RECON DENIED NO APPEAL FILED COUNTED NOT MAILED
Wednesday, November 8, 2023ACTION FOR REQ FOR RECON DENIED NO APPEAL FILED E-MAILED
Wednesday, November 8, 2023NOTIFICATION FOR REQ FOR RECON DENIED NO APPEAL FILED
Wednesday, November 29, 2023TEAS REQUEST FOR RECONSIDERATION RECEIVED
Wednesday, November 29, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, November 30, 2023EXPARTE APPEAL RECEIVED AT TTAB
Thursday, November 30, 2023JURISDICTION RESTORED TO EXAMINING ATTORNEY
Thursday, November 30, 2023EX PARTE APPEAL-INSTITUTED
Thursday, November 30, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, January 9, 2024EXAMINERS AMENDMENT -WRITTEN
Tuesday, January 9, 2024EXAMINERS AMENDMENT E-MAILED
Tuesday, January 9, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, January 9, 2024EXAMINER'S AMENDMENT ENTERED
Tuesday, January 9, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, January 9, 2024EXPARTE APPEAL TERMINATED
Wednesday, January 24, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 13, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 13, 2024PUBLISHED FOR OPPOSITION
Tuesday, April 9, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 17, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, September 17, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 17, 2024SOU EXTENSION 1 FILED
Tuesday, September 17, 2024SOU EXTENSION 1 GRANTED

Related Keywords

qualtrak biopharmaceutical labels mixes nucleotide foregoing clinical vitro nucleic laboratory acid